Dược phẩm 📰 1 News →

IMP

Dược phẩm Imexpharm

56
-0.18%
Mkt Cap 1.5T
9.5
Strong Sell
Sentiment
+1.00
Impact
1.00
Momentum
-0.04
Fundamentals
+0.00
Volume
0.54
News Sentiment
Articles Analyzed
4
Dominant Sentiment
Negative
Negative 2
Neutral 1
Positive 1
Recent News
Apr 20, 2026

VNDirect (VND) posted Q1 2026 pre-tax profit of VND 681 billion, a 43% year-on-year increase, as part of a broader earnings release wave. TP Securities (ORS) led with a 1,961% surge to VND 42 billion, while ACBS grew 67% to VND 303 billion, highlighting divergent performance in Vietnam's securities sector amid mixed market conditions.

earnings beat
10 Positive
Apr 10, 2026

The Ministry of Health has issued a directive to ensure a stable, timely, and reasonably priced supply of essential drugs, urging provinces, hospitals, and pharmaceutical companies to prevent shortages, hoarding, and unreasonable price increases while prioritizing domestic production.

↗ External source
7 Neutral

Multiple executives at Imexpharm sell shares citing personal financial adjustments; other transactions include Diamond Properties reducing NVL holdings, OCB insider sales, and foreign fund buying SHS shares.

↗ External source
6 Negative

Imexpharm (IMP) executives, including CEO Trần Thị Đào, registered to sell 607,400 shares (0.44% stake) from mid-April to mid-May 2026 for personal financial planning. The planned sales coincide with the company's annual meeting on April 22 and ambitious 2026 targets of VND 3,200B revenue (+9.8%) and VND 502B pre-tax profit (+12.6%).

insider trade
4 Negative
Related Stocks — Dược phẩm
DBD — Dược - Trang thiết bị y tế Bình Định DCL — Dược phẩm Cửu Long DHG — Dược Hậu Giang DMC — Xuất nhập khẩu Y tế Domesco LDP — Dược Lâm Đồng - Ladophar MED — Dược Trung ương Mediplantex TRA — Traphaco
Stock Analysis
Recent News Dashboard

Information provided for educational purposes only. Past performance does not guarantee future results. Data sourced from public Vietnamese market feeds.

Last updated: 2026-04-21T17:20:49Z.